Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital. Univ. Heart J. 2022;18(1):10-13. doi:10.3329/uhj.v18i1.57874